Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta
Clinical trial NCT05768854 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05768854
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-14
- Primary completion
- 2025-10-23
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.